GE HealthCare Technologies Stock Price | GEHC Stock Quote, News, and History | Markets Insider (2025)

87.31-0.05-0.06%

03:59:59 PM EDT 1/22/2025BTT

Plus500. 82% of retail CFD accounts lose money

NewsAnalyst DataAnalyst OpinionsInsider ActivityDividend Calendar



Best Online Brokers for Stock TradingWant to trade stocks and other assets? Don't lose hundreds of dollars in avoidable transaction costs! Discover the best brokers for stock trading and ordering other assets!

On Tuesday 01/21/2025 the closing price of the GE HealthCare Technologies share was $87.36 on BTT.Compared to the opening price on Tuesday 01/21/2025 on BTT of $87.23, this is a gain of 0.15%.GE HealthCare Technologies's market capitalization is $36.15 B by 456.87 M shares outstanding.

GE HealthCare Technologies Stock Snapshot

87.26

Bid

13.00

Bid Size

87.37

Ask

12.00

Ask Size

3:59 PM

Time

89,020.00

Volume

87.36

Prev. Close

87.23

Open

39.90 B

Market Cap in USD

456.87 M

Number of Shares

456.87 M

Total Number of Shares

86.95

Day Low

88.27

Day High

87.31

71.33

52 Week Low

94.48

52 Week High

87.31

0.12

Dividend in USD

0.16

Dividend Yield

25.57

P/E Ratio

96.85

Free Float in %

3.03

EPS in USD

15.67

Book Value per Share in USD

4.59

Cash Flow per Share in USD

GE HealthCare Technologies NewsMore News

TipRanks

Analysts Are Bullish on Top Healthcare Stocks: RAPT Therapeutics (RAPT), GE Healthcare Technologies Inc (GEHC)

TipRanks

Strategic Growth and Innovation Drive Joanne Wuensch’s Buy Rating for GE Healthcare Technologies

TipRanks

UCSF, GE HealthCare launch Care Innovation Hub for patient care

RTTNews

Sutter Health And GE HealthCare Team Up For AI-powered Imaging Advancements

Historical Prices for GE HealthCare Technologies

Loading..
DateOpenCloseDaily HighDaily Low

Price change over selected period:0%0

GE HealthCare Technologies Analyst Data

Total Analysts: 26

Buy Ratings: 15 Neutral Ratings: 10 Sell Ratings: 1

Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}

Price *Price Target

Lowest: 66.00 Median: 90.12 Highest: 110.00

*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.

GE HealthCare Technologies Analyst Opinions

  • All
  • Buy
  • Hold
  • Sell
DateAnalystRatingPrice
05/30/24Goldman SachsMaintained Hold$87neutral
05/01/24Bank of America Merrill LynchMaintained Hold$86neutral
05/01/24MizuhoMaintained Buy$105gut
04/11/24MizuhoMaintained Buy$110gut
04/04/24EvercoreMaintained Buy$100gut
04/03/24Citigroup Corp.Maintained Buy$103gut
04/01/24Argus Research Company Maintained Buy$110gut
02/15/24HSBCMaintained Buy$100gut
02/12/24Morgan StanleyMaintained Hold$86neutral
02/12/24UBSUpgraded to Hold$88neutral
02/07/24MizuhoMaintained Buy$96gut
12/04/23Morgan StanleyMaintained Hold$74neutral
11/30/23Jefferies & Company Inc.Maintained Hold$80neutral
11/27/23UBSDowngraded to Sell$66schlecht
09/19/23Citigroup Corp.Maintained Buy$82gut
08/16/23Wells Fargo & CoMaintained Buy$90gut
07/31/23Bank of America Merrill LynchMaintained Hold$82neutral
07/26/23Morgan StanleyMaintained Hold$78neutral
06/27/23Morgan StanleyMaintained Hold$76neutral
05/16/23Oppenheimer & Co. Inc.Maintained Buy$97gut
04/26/23MizuhoMaintained Buy$94gut
04/26/23UBSMaintained Hold$86neutral
04/19/23Piper SandlerMaintained Buy$95gut
04/18/23MizuhoMaintained Buy$92gut
04/10/23BTIG ResearchMaintained Holdneutral
03/13/23EvercoreMaintained Buy$90gut
02/17/23MizuhoMaintained Buy$90gut

GE HealthCare Technologies Estimates* in USD

2025202620272028
Revenue20,49221,40122,32923,005
Dividend0.160.220.37-
Dividend Yield (in %)0.18 %0.25 %0.42 %-
EPS4.665.235.756.31
P/E Ratio18.7316.7115.1913.85
EBIT3,3483,6454,0294,371
EBITDA3,9084,2104,4234,632
Net Profit2,0762,3392,5672,762
Net Profit Adjusted2,1422,4132,6602,907
Pre-Tax Profit2,8113,1643,5023,797
Pre-Tax Profit Reported2,8673,354--
EPS (Non-GAAP) ex. SOE4.665.235.756.31
EPS (GAAP)4.455.095.846.41
Gross Income8,6699,1479,4859,964
Cash Flow from Investing-402-414--
Cash Flow from Operations3,2083,422--
Cash Flow from Financing-1,545-1,197--
Cash Flow per Share5.626.13--
Free Cash Flow2,3902,4052,676-
Free Cash Flow per Share4.124.86--
Book Value per Share25.9530.82--
Net Debt3,246879-2,151-
Research & Development Exp.1,3501,3971,4271,467
Capital Expenditure464480474-
Selling, General & Admin. Exp.4,1724,2654,2824,351
Shareholder’s Equity12,33714,458--
Total Assets35,21036,644--
Previous Quarter
ending 12/31/24
Current Quarter
ending 03/31/25
Next Quarter
ending 06/30/25
Current Year
ending 12/31/25
Next Year
ending 12/31/26
Earnings Estimates
No. of Analysts1411111814
Average Estimate1.263 USD0.981 USD1.095 USD4.663 USD5.226 USD
Year Ago0.886 USD0.820 USD0.937 USD--
Publish Date2/13/20254/29/20257/29/2025--
Revenue Estimates
No. of Analysts13881714
Average Estimate5,335 USD4,770 USD4,975 USD20,492 USD21,401 USD
Year Ago5,206 USD4,650 USD4,839 USD--
Publish Date2/13/20254/29/20257/29/2025--

* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. USD

2023 2022 2021 2020 2019
Sales 19,552.00 18,341.00 17,585.00 17,164.00 16,633.00
Change of sales in % 6.60 4.30 2.45 3.19 -
Gross profit on sales 7,956.00 7,221.00 7,174.00 6,767.00 6,548.00
Gross profit on sales change in % 10.18 0.66 6.01 3.34 -
Operating income 2,788.00 2,564.00 2,795.00 2,720.00 2,124.00
Operating income change in % 8.74 -8.26 2.76 28.06 -
Income before tax 2,361.00 2,512.00 2,875.00 2,710.00 2,091.00
Income before tax change in % -6.01 -12.63 6.09 29.60 -
Income after tax 1,572.00 1,898.00 2,229.00 2,007.00 1,652.00
Income after tax change in % -17.18 -14.85 11.06 21.49 -

Balance Sheet in Mio. USD

2023 2022 2021 2020 2019
Total liabilities 25,144.00 17,947.00 9,412.00 9,254.00 -
Long-term liabilities per share 35.50 23.70 5.83 6.00 -
Equity 7,310.00 9,592.00 16,896.00 14,974.00 -
Equity change in % -23.77 -43.82 13.09 - -
Balance sheet total 32,454.00 27,539.00 26,308.00 24,228.00 -
Balance sheet total change in % 17.85 4.68 8.59 - -

Key Data in USD

2023 2022 2021 2020 2019
Sales per share 42.69 40.41 38.67 37.75 36.58
P/E ratio (year end quote, basic EPS) 25.57 13.83 - - -
P/E ratio (year end quote, diluted EPS) 25.57 13.83 - - -
P/E ratio (year end quote) 25.57 13.83 - - -
Dividend yield in % 0.16 0.00 - - -
Equity ratio in % 22.52 34.83 64.22 61.80 -
Debt ratio in % 77.48 65.17 35.78 38.20 -

GE HealthCare Technologies Insider Activity

NameDateshares tradedshares heldPricetype (sell/buy)option
Rott Roland11/05/20243,577.0024,298.0086.48Sell No
Rott Roland11/04/20249,698.0027,875.0087.65Sell No
Rackliffe Philip11/04/2024900.0012,715.0087.63Sell No
Rott Roland11/04/202413,275.0037,573.0040.40Buy No
Stacherski Kenneth R.10/31/202411,028.0027,055.0087.35Sell No
Arduini Peter J08/31/20245,859.00107,341.0084.82Sell No
Stacherski Kenneth R.08/31/2024458.0038,083.0084.82Sell No
SACCARO JAMES08/31/20241,740.0061,200.0084.82Sell No
Rackliffe Philip08/31/20241,388.0013,780.0084.82Sell No
Rackliffe Philip08/31/2024165.0013,615.0084.82Sell No
Jimenez Frank R08/31/20241,699.0074,097.0084.82Sell No
CULP H LAWRENCE JR08/16/2024291,053.00333,021.0084.80Sell No
Rott Roland08/14/20242,784.0024,983.00n/aBuy No
Holton Adam Y08/14/20244,396.004,396.00n/aBuy No
Holton Adam Y08/14/20248,499.0012,895.00n/aBuy No
Stacherski Kenneth R.08/13/202419,008.0038,541.0083.22Sell No
Westrick Thomas J.08/06/20242,750.0017,509.0080.78Sell No
O'Neill Kevin Michael08/02/20241,533.0022,477.0083.44Sell No
Rott Roland08/02/20241,630.0022,199.0083.44Sell No
Kass-Hout Taha05/27/20243,300.0067,300.0078.70Sell No
LESJAK CATHERINE A05/20/20242,440.006,024.00n/aBuy No
HOWELL LLOYD JR05/20/20242,440.006,024.00n/aBuy No
Hochman Rodney F05/20/20242,440.007,238.00n/aBuy No
Hochman Rodney F05/20/20241,525.008,763.00n/aBuy No
Madden Anne T05/20/20241,525.008,763.00n/aBuy No

GE HealthCare Technologies Dividend Calendar

Date Name Dividend *yield Currency
2023 GE HealthCare Technologies 0.12 0.16 USD
2022 GE HealthCare Technologies 0.00 0.00 USD
2021 GE HealthCare Technologies - - USD
2020 GE HealthCare Technologies - - USD
2019 GE HealthCare Technologies - - USD

*Yield of the Respective Date

GE HealthCare Technologies Calendar

Event Estimate Info Date
Earnings Report 1.263 USD Q4 2024 Earnings Release 02/13/2025
Earnings Report 0.981 USD Q1 2025 Earnings Release 04/29/2025
Earnings Report 1.095 USD Q2 2025 Earnings Release 07/29/2025
Earnings Report 1.185 USD Q3 2025 Earnings Release 10/29/2025
Earnings Report 1.364 USD Q4 2025 Earnings Release 02/02/2026

GE HealthCare Technologies Past Events

Event Actual EPS Info Date
Earnings Report 1.020 USD Q3 2024 Earnings Release 10/30/2024
Earnings Report 0.930 USD Q2 2024 Earnings Release 07/31/2024
Annual General Meeting - Annual General Meeting 05/21/2024
Earnings Report 0.810 USD Q1 2024 Earnings Release 04/30/2024
Earnings Report 0.880 USD Q4 2023 Earnings Release 02/06/2024
Earnings Report 0.820 USD Q3 2023 Earnings Release 10/31/2023
Earnings Report 0.910 USD Q2 2023 Earnings Release 07/25/2023
Annual General Meeting - Annual General Meeting 05/23/2023
Earnings Report 0.410 USD Q1 2023 Earnings Release 04/25/2023
Earnings Report 1.221 USD Q4 2022 Earnings Release 01/30/2023

GE HealthCare Technologies Profile

GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company’s history roots back to the year 1892 and it was incorporated on May 16, 2022 and is headquartered in Chicago, IL.

GE HealthCare Technologies Shareholder

Ownerin %
Freefloat96.85
Capital Research & Management Co. (Global Investors)12.74
Capital Research & Management Co. (Global Investors)12.74
Vanguard Group, Inc. (Subfiler)10.59
The Vanguard Group, Inc.10.18
American Funds Investment Company of America5.29
State Street Corp.4.07
Dodge & Cox3.65
BlackRock Fund Advisors3.28
Vanguard Total Stock Market ETF3.13
American Funds Growth Fund of America2.98
General Electric Co. (Investment Company)2.91
GE Aerospace2.91
Vanguard 500 Index Fund2.71
Geode Capital Management LLC2.40

Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

GE HealthCare Technologies Management

NameJob
Parminder BhatiaChief AI Officer
George NewcombChief Accounting Officer & Controller
Rana StrellisChief Corporate Marketing & Communications Officer
Abigail Epane-OsualaChief Diversity, Equity & Inclusion Officer
Roland RottChief Executive Officer-Imaging
Thomas J. WestrickChief Executive Officer-Patient Care Solutions
James K. SaccaroChief Financial Officer & Vice President
Jahid KhandakerChief Information Officer
Carolynne BordersChief Investor Relations Officer
Danielle HalstromChief Marketing & Communications Officer
Adam HoltonChief People Officer
Laila A. GurneyChief Quality & Regulatory Officer
Taha Kass-HoutChief Science & Technology Officer
Brian MontgomeryChief Strategy Officer
Kenneth R. StacherskiChief Supply Chain & Services Officer
Catherine A. LesjakIndependent Director
Phoebe L. YangIndependent Director
Rodney F. HochmanIndependent Director
Tomislav MihaljevicIndependent Director
William Joseph StrombergIndependent Director
Anne T. MaddenIndependent Director
Lloyd W. HowellIndependent Director
Risa J. Lavizzo-MoureyLead Independent Director
H. Lawrence CulpNon-Executive Chairman
Philip D. RackliffePresident & Chief Executive Officer-Ultrasound
Peter J. ArduiniPresident, Chief Executive Officer & Director
Frank R. JimenezSecretary & General Counsel
GE HealthCare Technologies Stock Price | GEHC Stock Quote, News, and History | Markets Insider (2025)
Top Articles
Latest Posts
Recommended Articles
Article information

Author: Rob Wisoky

Last Updated:

Views: 5575

Rating: 4.8 / 5 (48 voted)

Reviews: 95% of readers found this page helpful

Author information

Name: Rob Wisoky

Birthday: 1994-09-30

Address: 5789 Michel Vista, West Domenic, OR 80464-9452

Phone: +97313824072371

Job: Education Orchestrator

Hobby: Lockpicking, Crocheting, Baton twirling, Video gaming, Jogging, Whittling, Model building

Introduction: My name is Rob Wisoky, I am a smiling, helpful, encouraging, zealous, energetic, faithful, fantastic person who loves writing and wants to share my knowledge and understanding with you.